SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 1 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $39,000 | -53.0% | 164,000 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $83,000 | 0.0% | 164,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $83,000 | -45.8% | 164,000 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $153,000 | +64.5% | 164,000 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $93,000 | -9.7% | 164,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $103,000 | -17.6% | 164,000 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $125,000 | -55.7% | 164,000 | 0.0% | 0.01% | -60.0% |
| Q3 2016 | $282,000 | -4.4% | 164,000 | 0.0% | 0.02% | -6.2% |
| Q2 2016 | $295,000 | -1.0% | 164,000 | +26.2% | 0.02% | -20.0% |
| Q4 2015 | $298,000 | – | 130,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
| MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
| 683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
| Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
| BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
| Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
| Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |